Patrick Michael Murphy - 28 Jun 2021 Form 4 Insider Report for DEXCOM INC (DXCM)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
29 Jun 2021, 19:05:45 UTC
Prior SEC filing
27 May 2021
Next SEC filing
27 Jul 2021
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
By: Jereme Sylvain For: Patrick M Murphy

Key filing fact

Patrick Michael Murphy filed Form 4 for DEXCOM INC (DXCM) on 29 Jun 2021.

Key facts

  • This page summarizes Patrick Michael Murphy's Form 4 filing for DEXCOM INC (DXCM).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 29 Jun 2021, 19:05.

Change

  • Previous filing in this sequence was filed on 27 May 2021.
  • Current net transaction value: -$215,745.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

DXCM transaction

Common Stock

Sale

Transaction value
$215,745
Shares
-500
Change %
-2.7%
Price
$431.49
Shares after
18,241
Date
28 Jun 2021
Ownership
Direct
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

On August 28, 2020, Mr. Murphy adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Murphy. The shares set forth above were sold pursuant to the 10b5-1 Plan.

Footnote F2

Included in this number are 15,413 unvested restricted stock units, 5,634 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 5,874 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 3,905 of which were granted on March 8, 2019 and shall vest through March 8, 2022.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .